Japan says US trade deal not settled, awaits pharma, chip orders

Japan's top tariff negotiator, Ryosei Akazawa, stated that the broad trade agreement with the United States remains "not settled" due to Washington's failure to issue expected presidential orders for most-favored-nation status on pharmaceuticals and semiconductors. While orders for general and auto tariffs have been issued, Akazawa confirmed Tokyo will continue to press for the outstanding orders and will analyze the economic impact of existing U.S. auto tariff adjustments, signaling ongoing points of contention in the bilateral trade relationship.

Analysis

The current market landscape is characterized by conflicting signals, blending macroeconomic headwinds with strong thematic momentum. A primary point of friction is the unsettled U.S.-Japan trade agreement, as confirmed by Japan's top negotiator, Ryosei Akazawa. The failure of the U.S. to issue presidential orders for most-favored-nation status on pharmaceuticals and semiconductors introduces significant uncertainty for these key sectors, even as orders concerning auto tariffs have been issued. This unresolved trade policy issue, which carries a moderately negative sentiment score (-0.4), is compounded by signs of a cooling U.S. labor market, evidenced by a headline report of a weaker-than-expected 22,000 jobs added in August. Juxtaposed against this macro uncertainty is the powerful performance within the artificial intelligence theme. The article highlights past high-flyers like Super Micro Computer (+185%) and AppLovin (+157%) as examples of AI-driven market winners, reflected in their strong positive per-ticker sentiment scores (0.8 and 0.7, respectively). This suggests that while broad economic indicators and trade relations are creating a cautious tone, specific technology sectors continue to exhibit robust, momentum-driven growth.

Key Decisions for Investors

• Investors with exposure to U.S. and Japanese pharmaceutical and semiconductor industries should closely monitor trade negotiations, as the 'not settled' status introduces potential tariff and supply chain risks.
• The weaker-than-expected U.S. jobs data suggests a cooling economy, warranting a review of portfolio exposure to cyclical sectors and potentially increasing allocations to more defensive assets.
• While the specific stock mentions are promotional, the outsized returns cited for AI-related names like SMCI and APP underscore the powerful momentum in the sector; however, investors should be cautious of chasing performance and assess valuations carefully.
• Given the divergence between negative macroeconomic data and strong technology-themed momentum, a barbell strategy could be prudent, balancing defensive holdings with selective exposure to secular growth areas like artificial intelligence.